Two Abstracts Selected for Presentation as part of the Meeting’s Special Poster Collections
Research Focuses on the Use of Thin Film Freezing to Produce Dry Powder Inhaled Formulations of Monoclonal Antibodies and Applications of Machine Learning to Predict Aerosol Performance of Dry Powders for Inhalation
FORT WORTH, Texas, Sept. 22, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the acceptance of multiple abstracts featuring application of the Company’s Thin Film Freezing Technology at the upcoming American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 Meeting, which is being held in Boston from October 16-19, 2022. Research from two abstracts has been selected for presentation as part of the “Special Poster Collections” at the meeting.
The research being presented was led by colleagues in the laboratory of Dr. Robert O. Williams III, Thin Film Freezing inventor and Special Advisor to TFF, at the University of Texas at Austin. The results highlight the broad applicability of Thin Film Freezing, including the ability to produce stable, aerosolizable dry powder formulations of monoclonal antibodies for lung delivery, and also demonstrate how the application of deep learning methods such as machine learning and artificial intelligence can be used to efficiently develop and measure the aerosol performance of powders made via Thin Film Freezing. As TFF continues to expand its network of collaborations in biologics, the research being done by Dr. Williams and colleagues will guide the company’s knowledge-building and ongoing progress.
Presentation details are as follows:
“Applications of Deep Learning to Predict Aerosol Performance of Dry Powders for Inhalation”
Tuesday, October 18, 2022, 10:30-11:30 AM ET
“Inhalation Dry Powders of Monoclonal Antibodies Made by Thin-Film Freeze-Drying”
Wednesday, October 19, 2022, 10:30-11:30 AM ET
Scientists in Dr. Williams’ lab will also present four additional posters at the conference, highlighting the applicability of Thin Film Freezing in alternative formulations for nicotine, antiviral treatments for COVID-19 and other areas. Full details on the data being presented can be found on the conference website.
ABOUT AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS (AAPS)
Founded in 1986, the American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 7,000 individual members and over 10,000 actively participating stakeholders employed in academia, industry, government, and other pharmaceutical science related research institutes worldwide.
ABOUT TFF PHARMACEUTICALS’ THIN FILM FREEZING TECHNOLOGY PLATFORM
TFF Pharmaceuticals’ proprietary Thin Film Freezing (TFF) technology allows for the transformation of both existing compounds and new chemical entities into dry powder formulations exhibiting unique characteristics and benefits. The Thin Film Freezing process is a particle engineering process designed to generate dry powder particles with advantageous properties for inhalation, as well as parenteral, nasal, oral, topical and ocular routes of administration. The process can be used to engineer powders for direct delivery to the site of need, circumventing challenges of systemic administration and leading to improved bioavailability, faster onset of action, and improved safety and efficacy. The ability to deliver therapies directly to the target organ, such as the lung, allows TFF powders to be administered at lower doses compared to oral drugs, reducing unwanted toxicities and side effects. Laboratory data suggests the aerodynamic properties of the powders created by Thin Film Freezing can deliver as much as 75% of the dose to the deep lung. Thin Film Freezing does not introduce heat, shear stress, or other forces that can damage more complex therapeutic components, such as fragile biologics, and instead enables the reformulation of these materials into easily stored and temperature-stable dry powders, making therapeutics and vaccines more accessible for distribution worldwide. The advantages of Thin Film Freezing can be used to enhance traditional delivery or combined to enable next-generation pharmaceutical products.
TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaging patented rapid freezing technology to develop and transform medicines into potent dry powder formulations for better efficacy, safety and stability. The company’s versatile Thin Film Freezing (TFF) technology platform has broad applicability to convert any drug, including vaccines, small and large molecules and biologics, into an elegant dry powder highly advantageous for inhalation, with improved absorption so drugs can also be delivered to the eyes, nose and topically to the skin. TFF has two lead drug candidates in the clinic: Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder, and continues to expand its pipeline by collaborating with a broad array of pharmaceutical companies, academic institutions and government partners to revolutionize healthcare around the globe. The TFF Platform is protected by 120+ patents issued or pending in the U.S. and internationally. To learn more about TFF Pharmaceuticals and its product candidates, visit the Company’s website at https://tffpharma.com.
This press release contains forward-looking statements regarding TFF Pharmaceuticals, Inc., including the expectations for its continued development of Voriconazole Inhalation Powder, Tacrolimus Inhalation Powder, the benefits of the Company’s TFF platform and the Company’s plans to add to its existing pipeline of product candidates. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (i) the risk that the Company may not be able to successfully conclude clinical testing or obtain pre-market approval of its Voriconazole Inhalation Powder, Tacrolimus Inhalation Powder or any of its other dry powder product candidates, (ii) no drug product incorporating the TFF platform has received FDA pre-market approval or otherwise been incorporated into a commercial drug product, (iii) the Company has no current agreements or understandings with any large pharmaceutical companies for the development of a drug product incorporating the TFF Platform, (iv) the risk that the Company will not be able to conclude a long-term commercial agreement with any third-party, and (v) those other risks disclosed in the section “Risk Factors” included in the Company’s 2021 Annual Report on Form 10-K filed with the SEC on March 24, 2022. TFF Pharmaceuticals cautions readers not to place undue reliance on any forward-looking statements. TFF Pharmaceuticals does not undertake, and specifically disclaims, any obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur, except as required by law.
Investor Relations Contact: Corey Davis, Ph.D. LifeSci Advisors (212) 915-2577 cdavis@lifesciadvisors.com
Media Contact: Gwendolyn Schanker LifeSci Communications (269) 921-3607 gschanker@lifescicomms.com
Deere's brand dominates in the U.S., but not in international markets. That could change drastically over the next decade.
Monday will be a monumental day for the "history of humankind" as a high-speed spacecraft smashes into an asteroid at nearly 15,000 mph.
The deal includes exclusive use and development of existing industrial NASA infrastructure to develop and test reusable engines for the company's Neutron rocket.
Guess we can soon find out how big the Venn diagram intersection is between fans of the two.
HONG KONG—An increasing number of scientists and engineers of Chinese descent are giving up tenured positions at top-tier American universities to leave for China or elsewhere, in a sign of the U.S.’s fading appeal for a group that has been a driver of innovation. The trend, driven in part by what many of the scholars describe as an increasingly hostile political and racial environment, has caused the Biden administration to work with scholars of Chinese descent to address concerns. More than 1,400 U.S.-trained Chinese scientists dropped their U.S. academic or corporate affiliation for a Chinese one in 2021, a 22% jump from the previous year, according to data gathered by researchers from Princeton University, Harvard University and the Massachusetts Institute of Technology.
Yahoo Finance's Akiko Fujita discusses the latest images coming from NASA's James Webb space telescope that capture Neptune's rings.
Engineers are reviewing test data to determine if NASA can press ahead toward a September 27 launch target.
Is the cheese edible? What did it smell like? Much about the ancient cheese remains a mystery.
In the first-of-its kind, save-the-world experiment, NASA is about to clobber a small, harmless asteroid millions of miles away. A spacecraft named Dart will zero in on the asteroid Monday, intent on slamming it head-on at 14,000 mph (22,500 kph). The impact should be just enough to nudge the asteroid into a slightly tighter orbit around its companion space rock — demonstrating that if a killer asteroid ever heads our way, we’d stand a fighting chance of diverting it.
NASA is about to clobber a small, harmless asteroid millions of miles away in a first of its kind experiment to test the ability of warding off a threatening space rock. (Sept. 22)
Couples who sleep together do not always sleep better
The Space Launch System edges closer to a maiden flight after concluding a tanking demonstration.
Billionaire believe Starship is ready to fly into space this fall
When an undersea volcano erupted in Tonga in January, its watery blast was huge and unusual — and scientists are still trying to understand its impacts. The volcano, known as Hunga Tonga-Hunga Ha’apai, shot millions of tons of water vapor high up into the atmosphere, according to a study published Thursday in the journal Science. The researchers estimate the eruption raised the amount of water in the stratosphere — the second layer of the atmosphere, above the range where humans live and breathe — by around 5%.
Partnering with the Astronaut Scholarship Foundation to invest in the future of STEM and space exploration
Nasa-backed SpinLaunch plans to make access to space cheaper, quicker and more environmentally friendly
NASA's DART spacecraft is on track to crash into an asteroid, just as planned. Abhishek Tripathi, Director of Mission Operations at the Space Sciences Lab at UC Berkeley explains to KTVU's Cristina Rendon and Jana Katsuyama what the program is all about.
The best nights of all of 2022 to see Jupiter in the night sky are about to take place as the planet takes center stage in the night sky, a showing unlike any other in nearly six decades. The sun, Earth and Jupiter will nearly align perfectly in the solar system on Monday, Sept. 26, during an event that happens once every 13 months called the Jupiter opposition. This is also around the same time that the gas giant is closest to the Earth. Just one day before opposition, Jupiter will be around 36
An ancient shipwreck found off the shore of Israel and loaded with cargo from all over the Mediterranean shows that traders from the West still came to port even after the Islamic conquest of the Holy Land, researchers say. Whatever the reason, the merchant ship made from fir and walnut trees and carrying containers with delights from far-off lands sank in the shallow waters off what is today the Israeli coastal community of Maagan Michael more than 1,200 years ago. The shipwreck, dated to the 7th or 8th century AD, is evidence that trade persisted with the rest of the Mediterranean despite the religious divide, said Deborah Cvikel, a nautical archaeologist at the University of Haifa and director of the dig.
“We printed up too much money, and just thought the party would never end,” Icahn said, adding that with the Fed raising rates to fight inflation, "the party's over."